Alexander Levitzki
Alexander Levitzki · Science & Medicine
Biochemist who pioneered signal transduction inhibitors (tyrphostins) as cancer drugs
1940, Jerusalem, Mandatory Palestine
Israel
Alexander Levitzki is recognized among Jewish contributors to Science & Medicine — Biochemist who pioneered signal transduction inhibitors (tyrphostins) as cancer drugs
Levitzki, an Israeli biochemist of Ukrainian-Jewish descent born in Jerusalem, pioneered the concept of signal-transduction therapy at the Hebrew University. His laboratory created the first tyrphostins, tyrosine-kinase inhibitors that block cancer-driving signals without harming normal kinases, helping to launch the era of targeted cancer drugs. He received the Israel Prize (1990) and the Wolf Prize in Medicine (2005).
Verify and go deeper with these external references.
Source: Jinfo.org — Jews in Biomedical Science
This page is published in seven languages from an English source. The translations are reviewed, but a mistake can still slip through. If you spot one on this profile — a wrong word, a lost date, a sentence that says something the English does not — please tell us.
Biochemist who pioneered signal transduction inhibitors (tyrphostins) as cancer drugs
Source: Jinfo.org — Jews in Biomedical Science
Similar Contributors
Joseph Schlessinger
Abraham Abuchowski
Alfred Gilman
Bert Vogelstein
